| Gene symbol | BIRC5 | Synonyms | API4, EPR-1 | Type of gene | protein-coding |
| Chromosome | 17 | Map location | 17q25.3 | dbXrefs | |
| Description | baculoviral IAP repeat containing 5 | ||||
| Gene symbol | TERT | Synonyms | CMM9, DKCA2, DKCB4, EST2, PFBMFT1, TCS1, TP2, TRT, hEST2, hTRT | Type of gene | protein-coding |
| Chromosome | 5 | Map location | 5p15.33 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | telomerase reverse transcriptase | ||||
| GTO ID | GTC1329 |
| Trial ID | NCT00961844 |
| Disease | Malignant Adenoma |
| Altered gene | TERT|BIRC5 |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | mRNA vaccine |
| Treatment | DC Vaccine |
| Co-treatment | Temozolomide |
| Phase | Phase1|Phase2 |
| Recruitment status | Terminated |
| Title | Phase I/II Trial for Vaccine Therapy With Dendritic Cells - Transfected With hTERT-, Survivin- and Tumor Cell Derived mRNA + ex Vivo T Cell Expansion and Reinfusion in Patients With Metastatic Malignant Melanoma |
| Year | 2009 |
| Country | Norway |
| Company sponsor | Steinar Aamdal |
| Other ID(s) | DC-004|2008-006253-41 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||
|
|||||||